Global Botulinum Toxin Type A for Injection Market Growth 2022-2028
Botulinum toxin type A for injection is indicated for blepharospasm, hemifacial spasm and related focal dystonia. Temporary improvement of moderate to severe frown lines caused by activity of the corrugator supercilii and/or procerus muscles in adults 65 years of age and younger.
The global market for Botulinum Toxin Type A for Injection is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Botulinum Toxin Type A for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Botulinum Toxin Type A for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Botulinum Toxin Type A for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Botulinum Toxin Type A for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Botulinum Toxin Type A for Injection players cover Ipsen, Hugel Aesthetics, Allergan Pharmaceuticals Ireland, Lanzhou Institute of Biological Products and Inibio and etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Botulinum Toxin Type A for Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Botulinum Toxin Type A for Injection market, with both quantitative and qualitative data, to help readers understand how the Botulinum Toxin Type A for Injection market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Botulinum Toxin Type A for Injection market and forecasts the market size by Type (50 Units/Bottle and 100 Units/Bottle,), by Application (Strabismus, Facial Spasms and Wrinkle Beauty,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
50 Units/Bottle
100 Units/Bottle
Segmentation by application
Strabismus
Facial Spasms
Wrinkle Beauty
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Ipsen
Hugel Aesthetics
Allergan Pharmaceuticals Ireland
Lanzhou Institute of Biological Products
Inibio
Galderma
Chapter Introduction
Chapter 1: Scope of Botulinum Toxin Type A for Injection, Research Methodology, etc.
Chapter 2: Executive Summary, global Botulinum Toxin Type A for Injection market size (sales and revenue) and CAGR, Botulinum Toxin Type A for Injection market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Botulinum Toxin Type A for Injection sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Botulinum Toxin Type A for Injection sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Botulinum Toxin Type A for Injection market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Ipsen, Hugel Aesthetics, Allergan Pharmaceuticals Ireland, Lanzhou Institute of Biological Products, Inibio and Galderma, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Botulinum Toxin Type A for Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Botulinum Toxin Type A for Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Botulinum Toxin Type A for Injection by Country/Region, 2017, 2022 & 2028
2.2 Botulinum Toxin Type A for Injection Segment by Type
2.2.1 50 Units/Bottle
2.2.2 100 Units/Bottle
2.3 Botulinum Toxin Type A for Injection Sales by Type
2.3.1 Global Botulinum Toxin Type A for Injection Sales Market Share by Type (2017-2022)
2.3.2 Global Botulinum Toxin Type A for Injection Revenue and Market Share by Type (2017-2022)
2.3.3 Global Botulinum Toxin Type A for Injection Sale Price by Type (2017-2022)
2.4 Botulinum Toxin Type A for Injection Segment by Application
2.4.1 Strabismus
2.4.2 Facial Spasms
2.4.3 Wrinkle Beauty
2.5 Botulinum Toxin Type A for Injection Sales by Application
2.5.1 Global Botulinum Toxin Type A for Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Botulinum Toxin Type A for Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Botulinum Toxin Type A for Injection Sale Price by Application (2017-2022)
3 Global Botulinum Toxin Type A for Injection by Company
3.1 Global Botulinum Toxin Type A for Injection Breakdown Data by Company
3.1.1 Global Botulinum Toxin Type A for Injection Annual Sales by Company (2020-2022)
3.1.2 Global Botulinum Toxin Type A for Injection Sales Market Share by Company (2020-2022)
3.2 Global Botulinum Toxin Type A for Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Botulinum Toxin Type A for Injection Revenue by Company (2020-2022)
3.2.2 Global Botulinum Toxin Type A for Injection Revenue Market Share by Company (2020-2022)
3.3 Global Botulinum Toxin Type A for Injection Sale Price by Company
3.4 Key Manufacturers Botulinum Toxin Type A for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Botulinum Toxin Type A for Injection Product Location Distribution
3.4.2 Players Botulinum Toxin Type A for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Botulinum Toxin Type A for Injection by Geographic Region
4.1 World Historic Botulinum Toxin Type A for Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Botulinum Toxin Type A for Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Botulinum Toxin Type A for Injection Annual Revenue by Geographic Region
4.2 World Historic Botulinum Toxin Type A for Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Botulinum Toxin Type A for Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Botulinum Toxin Type A for Injection Annual Revenue by Country/Region
4.3 Americas Botulinum Toxin Type A for Injection Sales Growth
4.4 APAC Botulinum Toxin Type A for Injection Sales Growth
4.5 Europe Botulinum Toxin Type A for Injection Sales Growth
4.6 Middle East & Africa Botulinum Toxin Type A for Injection Sales Growth
5 Americas
5.1 Americas Botulinum Toxin Type A for Injection Sales by Country
5.1.1 Americas Botulinum Toxin Type A for Injection Sales by Country (2017-2022)
5.1.2 Americas Botulinum Toxin Type A for Injection Revenue by Country (2017-2022)
5.2 Americas Botulinum Toxin Type A for Injection Sales by Type
5.3 Americas Botulinum Toxin Type A for Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Botulinum Toxin Type A for Injection Sales by Region
6.1.1 APAC Botulinum Toxin Type A for Injection Sales by Region (2017-2022)
6.1.2 APAC Botulinum Toxin Type A for Injection Revenue by Region (2017-2022)
6.2 APAC Botulinum Toxin Type A for Injection Sales by Type
6.3 APAC Botulinum Toxin Type A for Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Botulinum Toxin Type A for Injection by Country
7.1.1 Europe Botulinum Toxin Type A for Injection Sales by Country (2017-2022)
7.1.2 Europe Botulinum Toxin Type A for Injection Revenue by Country (2017-2022)
7.2 Europe Botulinum Toxin Type A for Injection Sales by Type
7.3 Europe Botulinum Toxin Type A for Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Botulinum Toxin Type A for Injection by Country
8.1.1 Middle East & Africa Botulinum Toxin Type A for Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Botulinum Toxin Type A for Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Botulinum Toxin Type A for Injection Sales by Type
8.3 Middle East & Africa Botulinum Toxin Type A for Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Botulinum Toxin Type A for Injection
10.3 Manufacturing Process Analysis of Botulinum Toxin Type A for Injection
10.4 Industry Chain Structure of Botulinum Toxin Type A for Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Botulinum Toxin Type A for Injection Distributors
11.3 Botulinum Toxin Type A for Injection Customer
12 World Forecast Review for Botulinum Toxin Type A for Injection by Geographic Region
12.1 Global Botulinum Toxin Type A for Injection Market Size Forecast by Region
12.1.1 Global Botulinum Toxin Type A for Injection Forecast by Region (2023-2028)
12.1.2 Global Botulinum Toxin Type A for Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Botulinum Toxin Type A for Injection Forecast by Type
12.7 Global Botulinum Toxin Type A for Injection Forecast by Application
13 Key Players Analysis
13.1 Ipsen
13.1.1 Ipsen Company Information
13.1.2 Ipsen Botulinum Toxin Type A for Injection Product Offered
13.1.3 Ipsen Botulinum Toxin Type A for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Ipsen Main Business Overview
13.1.5 Ipsen Latest Developments
13.2 Hugel Aesthetics
13.2.1 Hugel Aesthetics Company Information
13.2.2 Hugel Aesthetics Botulinum Toxin Type A for Injection Product Offered
13.2.3 Hugel Aesthetics Botulinum Toxin Type A for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Hugel Aesthetics Main Business Overview
13.2.5 Hugel Aesthetics Latest Developments
13.3 Allergan Pharmaceuticals Ireland
13.3.1 Allergan Pharmaceuticals Ireland Company Information
13.3.2 Allergan Pharmaceuticals Ireland Botulinum Toxin Type A for Injection Product Offered
13.3.3 Allergan Pharmaceuticals Ireland Botulinum Toxin Type A for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Allergan Pharmaceuticals Ireland Main Business Overview
13.3.5 Allergan Pharmaceuticals Ireland Latest Developments
13.4 Lanzhou Institute of Biological Products
13.4.1 Lanzhou Institute of Biological Products Company Information
13.4.2 Lanzhou Institute of Biological Products Botulinum Toxin Type A for Injection Product Offered
13.4.3 Lanzhou Institute of Biological Products Botulinum Toxin Type A for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Lanzhou Institute of Biological Products Main Business Overview
13.4.5 Lanzhou Institute of Biological Products Latest Developments
13.5 Inibio
13.5.1 Inibio Company Information
13.5.2 Inibio Botulinum Toxin Type A for Injection Product Offered
13.5.3 Inibio Botulinum Toxin Type A for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Inibio Main Business Overview
13.5.5 Inibio Latest Developments
13.6 Galderma
13.6.1 Galderma Company Information
13.6.2 Galderma Botulinum Toxin Type A for Injection Product Offered
13.6.3 Galderma Botulinum Toxin Type A for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Galderma Main Business Overview
13.6.5 Galderma Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Botulinum Toxin Type A for Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Botulinum Toxin Type A for Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 50 Units/Bottle
Table 4. Major Players of 100 Units/Bottle
Table 5. Global Botulinum Toxin Type A for Injection Sales by Type (2017-2022) & (K Units)
Table 6. Global Botulinum Toxin Type A for Injection Sales Market Share by Type (2017-2022)
Table 7. Global Botulinum Toxin Type A for Injection Revenue by Type (2017-2022) & ($ million)
Table 8. Global Botulinum Toxin Type A for Injection Revenue Market Share by Type (2017-2022)
Table 9. Global Botulinum Toxin Type A for Injection Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Botulinum Toxin Type A for Injection Sales by Application (2017-2022) & (K Units)
Table 11. Global Botulinum Toxin Type A for Injection Sales Market Share by Application (2017-2022)
Table 12. Global Botulinum Toxin Type A for Injection Revenue by Application (2017-2022)
Table 13. Global Botulinum Toxin Type A for Injection Revenue Market Share by Application (2017-2022)
Table 14. Global Botulinum Toxin Type A for Injection Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Botulinum Toxin Type A for Injection Sales by Company (2020-2022) & (K Units)
Table 16. Global Botulinum Toxin Type A for Injection Sales Market Share by Company (2020-2022)
Table 17. Global Botulinum Toxin Type A for Injection Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Botulinum Toxin Type A for Injection Revenue Market Share by Company (2020-2022)
Table 19. Global Botulinum Toxin Type A for Injection Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Botulinum Toxin Type A for Injection Producing Area Distribution and Sales Area
Table 21. Players Botulinum Toxin Type A for Injection Products Offered
Table 22. Botulinum Toxin Type A for Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Botulinum Toxin Type A for Injection Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Botulinum Toxin Type A for Injection Sales Market Share Geographic Region (2017-2022)
Table 27. Global Botulinum Toxin Type A for Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Botulinum Toxin Type A for Injection Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Botulinum Toxin Type A for Injection Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Botulinum Toxin Type A for Injection Sales Market Share by Country/Region (2017-2022)
Table 31. Global Botulinum Toxin Type A for Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Botulinum Toxin Type A for Injection Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Botulinum Toxin Type A for Injection Sales by Country (2017-2022) & (K Units)
Table 34. Americas Botulinum Toxin Type A for Injection Sales Market Share by Country (2017-2022)
Table 35. Americas Botulinum Toxin Type A for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Botulinum Toxin Type A for Injection Revenue Market Share by Country (2017-2022)
Table 37. Americas Botulinum Toxin Type A for Injection Sales by Type (2017-2022) & (K Units)
Table 38. Americas Botulinum Toxin Type A for Injection Sales Market Share by Type (2017-2022)
Table 39. Americas Botulinum Toxin Type A for Injection Sales by Application (2017-2022) & (K Units)
Table 40. Americas Botulinum Toxin Type A for Injection Sales Market Share by Application (2017-2022)
Table 41. APAC Botulinum Toxin Type A for Injection Sales by Region (2017-2022) & (K Units)
Table 42. APAC Botulinum Toxin Type A for Injection Sales Market Share by Region (2017-2022)
Table 43. APAC Botulinum Toxin Type A for Injection Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Botulinum Toxin Type A for Injection Revenue Market Share by Region (2017-2022)
Table 45. APAC Botulinum Toxin Type A for Injection Sales by Type (2017-2022) & (K Units)
Table 46. APAC Botulinum Toxin Type A for Injection Sales Market Share by Type (2017-2022)
Table 47. APAC Botulinum Toxin Type A for Injection Sales by Application (2017-2022) & (K Units)
Table 48. APAC Botulinum Toxin Type A for Injection Sales Market Share by Application (2017-2022)
Table 49. Europe Botulinum Toxin Type A for Injection Sales by Country (2017-2022) & (K Units)
Table 50. Europe Botulinum Toxin Type A for Injection Sales Market Share by Country (2017-2022)
Table 51. Europe Botulinum Toxin Type A for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Botulinum Toxin Type A for Injection Revenue Market Share by Country (2017-2022)
Table 53. Europe Botulinum Toxin Type A for Injection Sales by Type (2017-2022) & (K Units)
Table 54. Europe Botulinum Toxin Type A for Injection Sales Market Share by Type (2017-2022)
Table 55. Europe Botulinum Toxin Type A for Injection Sales by Application (2017-2022) & (K Units)
Table 56. Europe Botulinum Toxin Type A for Injection Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Botulinum Toxin Type A for Injection Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Botulinum Toxin Type A for Injection Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Botulinum Toxin Type A for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Botulinum Toxin Type A for Injection Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Botulinum Toxin Type A for Injection Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Botulinum Toxin Type A for Injection Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Botulinum Toxin Type A for Injection Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Botulinum Toxin Type A for Injection Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Botulinum Toxin Type A for Injection
Table 66. Key Market Challenges & Risks of Botulinum Toxin Type A for Injection
Table 67. Key Industry Trends of Botulinum Toxin Type A for Injection
Table 68. Botulinum Toxin Type A for Injection Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Botulinum Toxin Type A for Injection Distributors List
Table 71. Botulinum Toxin Type A for Injection Customer List
Table 72. Global Botulinum Toxin Type A for Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Botulinum Toxin Type A for Injection Sales Market Forecast by Region
Table 74. Global Botulinum Toxin Type A for Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Botulinum Toxin Type A for Injection Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Botulinum Toxin Type A for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Botulinum Toxin Type A for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Botulinum Toxin Type A for Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Botulinum Toxin Type A for Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Botulinum Toxin Type A for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Botulinum Toxin Type A for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Botulinum Toxin Type A for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Botulinum Toxin Type A for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Botulinum Toxin Type A for Injection Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Botulinum Toxin Type A for Injection Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Botulinum Toxin Type A for Injection Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Botulinum Toxin Type A for Injection Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Botulinum Toxin Type A for Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Botulinum Toxin Type A for Injection Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Botulinum Toxin Type A for Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Botulinum Toxin Type A for Injection Revenue Market Share Forecast by Application (2023-2028)
Table 92. Ipsen Basic Information, Botulinum Toxin Type A for Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Ipsen Botulinum Toxin Type A for Injection Product Offered
Table 94. Ipsen Botulinum Toxin Type A for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Ipsen Main Business
Table 96. Ipsen Latest Developments
Table 97. Hugel Aesthetics Basic Information, Botulinum Toxin Type A for Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Hugel Aesthetics Botulinum Toxin Type A for Injection Product Offered
Table 99. Hugel Aesthetics Botulinum Toxin Type A for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Hugel Aesthetics Main Business
Table 101. Hugel Aesthetics Latest Developments
Table 102. Allergan Pharmaceuticals Ireland Basic Information, Botulinum Toxin Type A for Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Allergan Pharmaceuticals Ireland Botulinum Toxin Type A for Injection Product Offered
Table 104. Allergan Pharmaceuticals Ireland Botulinum Toxin Type A for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Allergan Pharmaceuticals Ireland Main Business
Table 106. Allergan Pharmaceuticals Ireland Latest Developments
Table 107. Lanzhou Institute of Biological Products Basic Information, Botulinum Toxin Type A for Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Lanzhou Institute of Biological Products Botulinum Toxin Type A for Injection Product Offered
Table 109. Lanzhou Institute of Biological Products Botulinum Toxin Type A for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Lanzhou Institute of Biological Products Main Business
Table 111. Lanzhou Institute of Biological Products Latest Developments
Table 112. Inibio Basic Information, Botulinum Toxin Type A for Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Inibio Botulinum Toxin Type A for Injection Product Offered
Table 114. Inibio Botulinum Toxin Type A for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Inibio Main Business
Table 116. Inibio Latest Developments
Table 117. Galderma Basic Information, Botulinum Toxin Type A for Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Galderma Botulinum Toxin Type A for Injection Product Offered
Table 119. Galderma Botulinum Toxin Type A for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Galderma Main Business
Table 121. Galderma Latest Developments
List of Figures
Figure 1. Picture of Botulinum Toxin Type A for Injection
Figure 2. Botulinum Toxin Type A for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Botulinum Toxin Type A for Injection Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Botulinum Toxin Type A for Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Botulinum Toxin Type A for Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 50 Units/Bottle
Figure 10. Product Picture of 100 Units/Bottle
Figure 11. Global Botulinum Toxin Type A for Injection Sales Market Share by Type in 2021
Figure 12. Global Botulinum Toxin Type A for Injection Revenue Market Share by Type (2017-2022)
Figure 13. Botulinum Toxin Type A for Injection Consumed in Strabismus
Figure 14. Global Botulinum Toxin Type A for Injection Market: Strabismus (2017-2022) & (K Units)
Figure 15. Botulinum Toxin Type A for Injection Consumed in Facial Spasms
Figure 16. Global Botulinum Toxin Type A for Injection Market: Facial Spasms (2017-2022) & (K Units)
Figure 17. Botulinum Toxin Type A for Injection Consumed in Wrinkle Beauty
Figure 18. Global Botulinum Toxin Type A for Injection Market: Wrinkle Beauty (2017-2022) & (K Units)
Figure 19. Global Botulinum Toxin Type A for Injection Sales Market Share by Application (2017-2022)
Figure 20. Global Botulinum Toxin Type A for Injection Revenue Market Share by Application in 2021
Figure 21. Botulinum Toxin Type A for Injection Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Botulinum Toxin Type A for Injection Revenue Market Share by Company in 2021
Figure 23. Global Botulinum Toxin Type A for Injection Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Botulinum Toxin Type A for Injection Revenue Market Share by Geographic Region in 2021
Figure 25. Global Botulinum Toxin Type A for Injection Sales Market Share by Region (2017-2022)
Figure 26. Global Botulinum Toxin Type A for Injection Revenue Market Share by Country/Region in 2021
Figure 27. Americas Botulinum Toxin Type A for Injection Sales 2017-2022 (K Units)
Figure 28. Americas Botulinum Toxin Type A for Injection Revenue 2017-2022 ($ Millions)
Figure 29. APAC Botulinum Toxin Type A for Injection Sales 2017-2022 (K Units)
Figure 30. APAC Botulinum Toxin Type A for Injection Revenue 2017-2022 ($ Millions)
Figure 31. Europe Botulinum Toxin Type A for Injection Sales 2017-2022 (K Units)
Figure 32. Europe Botulinum Toxin Type A for Injection Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Botulinum Toxin Type A for Injection Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Botulinum Toxin Type A for Injection Revenue 2017-2022 ($ Millions)
Figure 35. Americas Botulinum Toxin Type A for Injection Sales Market Share by Country in 2021
Figure 36. Americas Botulinum Toxin Type A for Injection Revenue Market Share by Country in 2021
Figure 37. United States Botulinum Toxin Type A for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Botulinum Toxin Type A for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Botulinum Toxin Type A for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Botulinum Toxin Type A for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Botulinum Toxin Type A for Injection Sales Market Share by Region in 2021
Figure 42. APAC Botulinum Toxin Type A for Injection Revenue Market Share by Regions in 2021
Figure 43. China Botulinum Toxin Type A for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Botulinum Toxin Type A for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Botulinum Toxin Type A for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Botulinum Toxin Type A for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Botulinum Toxin Type A for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Botulinum Toxin Type A for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Botulinum Toxin Type A for Injection Sales Market Share by Country in 2021
Figure 50. Europe Botulinum Toxin Type A for Injection Revenue Market Share by Country in 2021
Figure 51. Germany Botulinum Toxin Type A for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Botulinum Toxin Type A for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Botulinum Toxin Type A for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Botulinum Toxin Type A for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Botulinum Toxin Type A for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Botulinum Toxin Type A for Injection Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Botulinum Toxin Type A for Injection Revenue Market Share by Country in 2021
Figure 58. Egypt Botulinum Toxin Type A for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Botulinum Toxin Type A for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Botulinum Toxin Type A for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Botulinum Toxin Type A for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Botulinum Toxin Type A for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Botulinum Toxin Type A for Injection in 2021
Figure 64. Manufacturing Process Analysis of Botulinum Toxin Type A for Injection
Figure 65. Industry Chain Structure of Botulinum Toxin Type A for Injection
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets